Clinical Trial Information Request for Protocol 2021P000538 Title A Safety, Immunogenicity and Efficacy Phase 1/2a Study of a Heterologous Ad26Mos4HIV, MVA-BN-HIV Vaccine Regimen Plus Broadly Neutralizing Antibodies PGT121, PGDM1400 and VRC07-523LS in HIV-1 Infected Adults on Suppressive ART PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone